LiDCO Group plc (LON:LID)‘s stock had its “corporate” rating reissued by research analysts at FinnCap in a report issued on Wednesday. They presently have a GBX 14 ($0.18) price target on the stock. FinnCap’s price target would indicate a potential upside of 64.71% from the stock’s current price.

LiDCO Group plc (LON LID) traded up 11.48% during mid-day trading on Wednesday, reaching GBX 8.50. 1,877,227 shares of the company’s stock were exchanged. The stock has a 50-day moving average price of GBX 7.60 and a 200 day moving average price of GBX 6.78. LiDCO Group plc has a 52-week low of GBX 5.25 and a 52-week high of GBX 9.00. The company’s market cap is GBX 20.75 million.

TRADEMARK VIOLATION NOTICE: “LiDCO Group plc’s (LID) Corporate Rating Reiterated at FinnCap” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/06/07/lidco-group-plcs-lid-corporate-rating-reiterated-at-finncap.html.

In other LiDCO Group plc news, insider Peter Grant purchased 500,000 shares of the firm’s stock in a transaction dated Friday, March 31st. The stock was bought at an average cost of GBX 3 ($0.04) per share, with a total value of £15,000 ($19,382.35).

About LiDCO Group plc

LiDCO Group Plc is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment.

Receive News & Ratings for LiDCO Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiDCO Group plc and related companies with MarketBeat.com's FREE daily email newsletter.